In a Law360 article, attorneys examined what is next for drug importation and potential next steps after the U.S. Food and Drug Administration approved Florida’s drug importation program.
The authors provide an overview of the FDA rule, discuss hurdles before drug importation can begin, present legal challenges and analyze regulatory and other implications.
The article was authored by health care partner Margaux Hall, life sciences regulatory & compliance counsel Beth Weinman, and health care associates William Shefelman and Alexandra Kaye.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.